# Tocilizumab-anoh

NDC: 72606-050
Generic name: tocilizumab
Labeler / Manufacturer: CELLTRION USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20250126

FDA application: BLA761420

## Active ingredients

- TOCILIZUMAB: 400 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72606-050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60381a7e-d7ae-4384-925d-c19c418d1663